The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 19, 2019

Filed:

May. 07, 2015
Applicants:

Tron Translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenbe, Mainz, DE;

Biontech Rna Pharmaceuticals Gmbh, Mainz, DE;

Inventors:

Ugur Sahin, Mainz, DE;

Tim Beissert, Gross-Gerau, DE;

Marco Poleganov, Frankfurt, DE;

Stephanie Herz, Kasel, DE;

Lars Koste, Mainz, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); A61K 48/00 (2006.01); A61K 31/52 (2006.01); A61K 31/429 (2006.01); A61K 38/16 (2006.01); C12N 13/00 (2006.01); C12N 5/074 (2010.01); C12P 21/04 (2006.01);
U.S. Cl.
CPC ...
A61K 48/00 (2013.01); A61K 31/429 (2013.01); A61K 31/52 (2013.01); A61K 38/162 (2013.01); C12N 5/0696 (2013.01); C12N 13/00 (2013.01); C12N 2501/24 (2013.01); C12N 2501/602 (2013.01); C12N 2501/603 (2013.01); C12N 2501/604 (2013.01); C12N 2501/605 (2013.01); C12N 2501/606 (2013.01); C12N 2501/608 (2013.01); C12N 2501/65 (2013.01); C12N 2501/727 (2013.01); C12N 2506/1307 (2013.01); C12N 2510/00 (2013.01);
Abstract

The present invention relates to expressing RNA in cells and, in particular, enhancing viability of cells in which RNA is to be expressed. Specifically, the present invention provides methods for expressing RNA in cells comprising the steps of preventing engagement of IFN receptor by extracellular IFN and inhibiting intracellular IFN signalling in the cells. Thus, preventing engagement of IFN receptor by extracellular IFN and inhibiting intracellular IFN signalling in the cells allows repetitive transfer of RNA into the cells.


Find Patent Forward Citations

Loading…